Likewise, positron emission tomography (PET) tracers that are tau-specific are contributing to our understanding of the pathophysiology of Alzheimer’s disease, offering the ability to diagnose the disease earlier, as well as to customize and target treatments [248]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.